AI and CyberKnife for Cancer Treatment Improves Patient Outcomes

by | Sep 24, 2025 | Prostate Cancer

The CyberKnife system has been using AI technology long before it became a household word.
Artificial intelligence (AI) enhances the CyberKnife system by enabling advanced, real-time motion tracking and adaptive radiation delivery, improving precision and personalized treatment for patients. AI and CyberKnife technology allow for real-time adjustments to a patient’s movement, minimizing radiation exposure to healthy tissue and reducing treatment margins. 
How AI improves the CyberKnife system
  • Real-time motion tracking: AI-driven algorithms, such as Accuray’s Synchrony technology, create patient-specific models to track the motion of tumors and organs in real-time. This is especially useful for mobile tumors in areas like the lungs, liver, and prostate, where natural patient movements from breathing or digestion could compromise accuracy.
  • Adaptive radiotherapy: AI allows the system to analyze real-time imaging during treatment and recalculate the radiation dose to adapt to any anatomical changes. This process is more efficient than traditional methods and enables physicians to deliver a custom-tailored treatment plan each day.
  • Faster and more precise treatment planning: Deep learning models can perform tasks like contouring tumors and organs—which are traditionally done manually—with increased speed and consistency. This reduces the time needed for treatment planning from days to minutes and lessens inter-observer variability between clinicians.
  • Automated dose modulation: AI-powered systems can dynamically shape the radiation beam to improve dosage conformance to the tumor and account for motion-induced dose errors. For example, the latest CyberKnife models can use dozens of unique beams to deliver radiation with sub-millimeter precision. 
Benefits of AI integration
  • Increased accuracy: By continuously tracking the tumor’s exact location, AI-integrated CyberKnife systems can deliver radiation with exceptional precision, even when the patient moves. This protects nearby healthy tissue and vital organs from unnecessary radiation.
  • Fewer treatments and reduced side effects: Because the AI enables highly targeted, high-dose radiation, patients often require only a few treatment sessions. For instance, prostate cancer can be treated in five or fewer sessions, compared to 40 with traditional methods. This efficiency also leads to fewer side effects.
  • Better outcomes: AI allows for personalized treatment that factors in a patient’s specific anatomy and tumor characteristics. The combination of greater precision and personalized care improves the likelihood of treatment success.
  • Improved patient experience: Patients don’t need uncomfortable and restrictive head or body frames to remain perfectly still. The AI-guided system moves with them, allowing them to breathe normally during the painless, non-invasive procedure. 
Future Developments
  • Autonomous delivery: Future innovations may lead to fully autonomous AI-driven radiation delivery, with algorithms continuously refining treatment plans without human intervention.
  • Enhanced motion prediction: Research is focused on improving motion prediction algorithms to achieve even faster and more accurate real-time tracking.
  • Validation and regulation: To ensure patient safety and maintain trust, AI systems require rigorous validation, standardization, and regulatory oversight.